Classification génomique intégrée des tumeurs neuroendocrines hypophysaires : implications cliniques
Chiara Villa(Centre National de la Recherche Scientifique), Guillaume Assié(Centre National de la Recherche Scientifique), Roberta Armignacco(University of Florence), Amandine Septier(Centre National de la Recherche Scientifique), Bertrand Baussart(Centre National de la Recherche Scientifique), Mario Néou(Délégation Paris 5), Anne Jouinot, Ségolène Gaillard(Inserm), Michèle Bernier(Hôpital Foch), Karine Perlemoine(Inserm), Marie Laure Raffin‐Sanson(Inserm), Jérôme Bertherat(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
|Cancer Cell|2016|665
SDHA is a tumor suppressor gene causing paraganglioma
|Human Molecular Genetics|2010|651
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
|The Lancet Oncology|2009|536
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434